Detalhe da pesquisa
1.
A Randomized Trial Evaluating the Use of a Smart Water Bottle to Increase Fluid Intake in Stone Formers.
J Ren Nutr
; 32(4): 389-395, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35283036
2.
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 20(9): 1226-1238, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402321
3.
Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRß.
Bioorg Med Chem Lett
; 25(2): 372-7, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25435151
4.
Robotic Partial vs Radical Nephrectomy for Clinical T3a Tumors: A Narrative Review.
J Endourol
; 37(9): 978-985, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358403
5.
Immediate gemcitabine bladder instillation following bladder closure during robotic-assisted radical nephroureterectomy: a multi-institutional report of feasibility and initial outcomes.
Transl Androl Urol
; 12(8): 1229-1237, 2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680222
6.
Multi-institutional feasibility and safety outcomes of retroperitoneal robot-assisted partial nephrectomy in morbidly obese patients.
Transl Androl Urol
; 12(5): 700-707, 2023 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37305642
7.
Technique and outcomes of robotic-assisted retroperitoneal radical nephrectomy.
Transl Androl Urol
; 12(10): 1518-1527, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37969765
8.
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2-, PIK3CA-mutated breast cancers.
Genome Med
; 15(1): 28, 2023 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101291
9.
ER+, HER2- advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes.
Mol Oncol
; 17(10): 2000-2016, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892268
10.
The design, synthesis, and biological evaluation of PIM kinase inhibitors.
Bioorg Med Chem Lett
; 22(11): 3732-8, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22542012
11.
The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors.
Bioorg Med Chem Lett
; 22(15): 4979-85, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22765894
12.
Discovery of XL413, a potent and selective CDC7 inhibitor.
Bioorg Med Chem Lett
; 22(11): 3727-31, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22560567
13.
SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitors.
Bioorg Med Chem Lett
; 22(24): 7653-8, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23127890
14.
Growth-rate model predicts in vivo tumor response from in vitro data.
CPT Pharmacometrics Syst Pharmacol
; 11(9): 1183-1193, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731938
15.
Clinical Utility of Rigid Blue Light Cystoscopy: Results from a Post Procedure User Survey in a Prospective Multicenter Registry.
Urol Pract
; 9(1): 94-100, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37145566
16.
Comparison of PIK3CA Mutation Prevalence in Breast Cancer Across Predicted Ancestry Populations.
JCO Precis Oncol
; 6: e2200341, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36446041
17.
A Visual Scale for Improving Communication When Describing Gross Hematuria.
Urology
; 148: 32-36, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285214
18.
A Laparoscopic Approach to Parastomal Hernia Repair With Re-Siting of Urinary Stoma.
Urology
; 152: 199, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33484824
19.
MRI/PET Imaging in elevated PSA and localized prostate cancer: a narrative review.
Transl Androl Urol
; 10(7): 3117-3129, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430415
20.
Evaluating the Perceived Importance of Male Ejaculatory Function.
Urology
; 147: 162-166, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991911